• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白与帕金森病发病机制中免疫细胞的去甲肾上腺素能调节

α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis.

作者信息

Butkovich Laura M, Houser Madelyn C, Tansey Malú G

机构信息

Tansey Laboratory, Department of Physiology, School of Medicine, Emory University, Atlanta, GA, United States.

出版信息

Front Neurosci. 2018 Sep 11;12:626. doi: 10.3389/fnins.2018.00626. eCollection 2018.

DOI:10.3389/fnins.2018.00626
PMID:30258347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6143806/
Abstract

α-synuclein (α-syn) pathology and loss of noradrenergic neurons in the locus coeruleus (LC) are among the most ubiquitous features of Parkinson's disease (PD). While noradrenergic dysfunction is associated with non-motor symptoms of PD, preclinical research suggests that the loss of LC norepinephrine (NE), and subsequently its immune modulatory and neuroprotective actions, may exacerbate or even accelerate disease progression. In this review, we discuss the mechanisms by which α-syn pathology and loss of central NE may directly impact brain health by interrupting neurotrophic factor signaling, exacerbating neuroinflammation, and altering regulation of innate and adaptive immune cells.

摘要

α-突触核蛋白(α-syn)病理改变和蓝斑(LC)中去甲肾上腺素能神经元的丧失是帕金森病(PD)最普遍的特征之一。虽然去甲肾上腺素能功能障碍与PD的非运动症状有关,但临床前研究表明,LC中去甲肾上腺素(NE)的丧失以及随后其免疫调节和神经保护作用的丧失,可能会加剧甚至加速疾病进展。在这篇综述中,我们讨论了α-syn病理改变和中枢NE丧失可能通过中断神经营养因子信号传导、加剧神经炎症以及改变固有免疫细胞和适应性免疫细胞的调节而直接影响脑健康的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0068/6143806/53131d1b84d0/fnins-12-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0068/6143806/53131d1b84d0/fnins-12-00626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0068/6143806/53131d1b84d0/fnins-12-00626-g001.jpg

相似文献

1
α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis.α-突触核蛋白与帕金森病发病机制中免疫细胞的去甲肾上腺素能调节
Front Neurosci. 2018 Sep 11;12:626. doi: 10.3389/fnins.2018.00626. eCollection 2018.
2
Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.在去甲肾上腺素能神经元中表达人α-突触核蛋白的转基因小鼠会发展出蓝斑病理和帕金森病的非运动特征。
J Neurosci. 2020 Sep 23;40(39):7559-7576. doi: 10.1523/JNEUROSCI.1468-19.2020. Epub 2020 Aug 31.
3
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.A53T-α-突触核蛋白在小鼠蓝斑中的过表达诱导神经元和神经胶质细胞出现类似帕金森病的病变。
Acta Neuropathol Commun. 2018 May 10;6(1):39. doi: 10.1186/s40478-018-0541-1.
4
Noradrenergic dysfunction accelerates LPS-elicited inflammation-related ascending sequential neurodegeneration and deficits in non-motor/motor functions.去甲肾上腺素能功能障碍加速 LPS 诱导的炎症相关上行序贯神经退行性变和非运动/运动功能障碍。
Brain Behav Immun. 2019 Oct;81:374-387. doi: 10.1016/j.bbi.2019.06.034. Epub 2019 Jun 24.
5
The Neurotoxin DSP-4 Dysregulates the Locus Coeruleus-Norepinephrine System and Recapitulates Molecular and Behavioral Aspects of Prodromal Neurodegenerative Disease.神经毒素 DSP-4 扰乱蓝斑去甲肾上腺素能系统,并再现神经退行性疾病前驱期的分子和行为特征。
eNeuro. 2023 Jan 6;10(1). doi: 10.1523/ENEURO.0483-22.2022. Print 2023 Jan.
6
Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story.针对帕金森病及相关疾病中的去甲肾上腺素能系统:蓝斑的故事。
Neurochem Int. 2017 Jan;102:22-32. doi: 10.1016/j.neuint.2016.11.009. Epub 2016 Nov 27.
7
Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease.蓝斑神经元的放电增强和SK通道功能障碍在帕金森病前驱期的不同模型中是保守的。
Sci Rep. 2022 Feb 24;12(1):3180. doi: 10.1038/s41598-022-06832-1.
8
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.整合素 CD11b 介导小鼠帕金森病模型蓝斑去甲肾上腺素能神经元退行性变。
J Neuroinflammation. 2020 May 6;17(1):148. doi: 10.1186/s12974-020-01823-3.
9
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.脑内给予配体-ASO 缀合物可选择性降低双突变人 A30P*A53T*α-突触核蛋白转基因小鼠单胺能神经元中 α-突触核蛋白的积累。
Int J Mol Sci. 2021 Mar 13;22(6):2939. doi: 10.3390/ijms22062939.
10
Lesion of the Locus Coeruleus Damages Learning and Memory Performance in Paraquat and Maneb-induced Mouse Parkinson's Disease Model.蓝斑损伤损害百草枯和代森锰诱导的帕金森病模型小鼠的学习和记忆能力。
Neuroscience. 2019 Nov 1;419:129-140. doi: 10.1016/j.neuroscience.2019.09.006. Epub 2019 Oct 18.

引用本文的文献

1
REM Density, Leg Movements, and REM Sleep without Atonia: Differentiating Type 1 from Type 2 Narcolepsy Through Polysomnographic Analysis, a Preliminary Study.快速眼动睡眠密度、腿部运动及无张力快速眼动睡眠:通过多导睡眠图分析鉴别1型与2型发作性睡病的初步研究
Nat Sci Sleep. 2025 Sep 2;17:2079-2089. doi: 10.2147/NSS.S535919. eCollection 2025.
2
Affective and chronic fatigue symptoms are associated with serum neuronal damage markers in Parkinson's disease.情感和慢性疲劳症状与帕金森病患者血清神经元损伤标志物有关。
Sci Rep. 2025 Jul 1;15(1):20647. doi: 10.1038/s41598-025-07735-7.
3
Microglial dynamics and neuroinflammation in prodromal and early Parkinson's disease.

本文引用的文献

1
Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling.炎症诱导的抑郁症的缓解需要 T 淋巴细胞和内源性脑内白细胞介素-10 信号传导。
Neuropsychopharmacology. 2018 Dec;43(13):2597-2605. doi: 10.1038/s41386-018-0154-1. Epub 2018 Jul 16.
2
Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration.脑去甲肾上腺素的丧失引发神经炎症介导的氧化损伤和选择性尾到头神经退行性变。
Mol Neurobiol. 2019 Apr;56(4):2653-2669. doi: 10.1007/s12035-018-1235-1. Epub 2018 Jul 27.
3
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
前驱期及早期帕金森病中的小胶质细胞动态变化与神经炎症
J Neuroinflammation. 2025 May 21;22(1):136. doi: 10.1186/s12974-025-03462-y.
4
Evaluation of Neuroprotective Effect of Gut Microbe in Parkinson's Disease: An In Silico and In Vivo Approach.基于计算和实验的方法评价肠道微生物对帕金森病的神经保护作用。
Neuromolecular Med. 2024 Aug 1;26(1):32. doi: 10.1007/s12017-024-08799-w.
5
Long-Term Impact of Diffuse Traumatic Brain Injury on Neuroinflammation and Catecholaminergic Signaling: Potential Relevance for Parkinson's Disease Risk.弥漫性创伤性脑损伤对神经炎症和儿茶酚胺能信号的长期影响:对帕金森病风险的潜在相关性。
Molecules. 2024 Mar 26;29(7):1470. doi: 10.3390/molecules29071470.
6
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.遗传与生化研究进展:揭示帕金森病神经退行性变的病因发病机制。
Biomolecules. 2024 Jan 5;14(1):73. doi: 10.3390/biom14010073.
7
Temporal model for central sensitization: A hypothesis for mechanism and treatment using systemic manual therapy, a focused review.中枢敏化的时间模型:关于使用全身手法治疗的机制与治疗的假说,一篇综述
MethodsX. 2022 Nov 28;10:101942. doi: 10.1016/j.mex.2022.101942. eCollection 2023.
8
RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus.更新:重新利用研究来寻找具有 Lewy 体痴呆症活性的新型化合物——国际德尔菲共识。
Alzheimers Res Ther. 2022 Nov 11;14(1):169. doi: 10.1186/s13195-022-01103-7.
9
α-synuclein enfolds tyrosine hydroxylase and dopamine ß-hydroxylase, potentially reducing dopamine and norepinephrine synthesis.α-突触核蛋白包裹酪氨酸羟化酶和多巴胺β-羟化酶,可能会减少多巴胺和去甲肾上腺素的合成。
J Proteins Proteom. 2022 Jun;13(2):109-115. doi: 10.1007/s42485-022-00088-z. Epub 2022 May 21.
10
The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease.神经退行性老年综合征(NES)假说:阿尔茨海默病和帕金森病是同一种疾病的两面。
IBRO Neurosci Rep. 2022 Sep 26;13:330-343. doi: 10.1016/j.ibneur.2022.09.007. eCollection 2022 Dec.
A53T-α-突触核蛋白在小鼠蓝斑中的过表达诱导神经元和神经胶质细胞出现类似帕金森病的病变。
Acta Neuropathol Commun. 2018 May 10;6(1):39. doi: 10.1186/s40478-018-0541-1.
4
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.路易小体样α-突触核蛋白包涵体在黑质变性前引发反应性小胶质细胞增生。
J Neuroinflammation. 2018 May 1;15(1):129. doi: 10.1186/s12974-018-1171-z.
5
Decreased sleep quality in Parkinson's patients is associated with higher anxiety and depression prevalence and severity, and correlates with pain intensity and quality.帕金森病患者睡眠质量下降与焦虑和抑郁的较高患病率及严重程度相关,且与疼痛强度和性质相关。
Neurol Res. 2018 Aug;40(8):696-701. doi: 10.1080/01616412.2018.1462880. Epub 2018 Apr 17.
6
Atomoxetine, a selective norepinephrine reuptake inhibitor, improves short-term histological outcomes after hypoxic-ischemic brain injury in the neonatal male rat.托莫西汀是一种选择性去甲肾上腺素再摄取抑制剂,可改善新生雄性大鼠缺氧缺血性脑损伤后的短期组织学结果。
Int J Dev Neurosci. 2018 Nov;70:34-45. doi: 10.1016/j.ijdevneu.2018.03.011. Epub 2018 Mar 30.
7
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease.粪便免疫谱提示帕金森病存在胃肠道炎症。
Mov Disord. 2018 May;33(5):793-804. doi: 10.1002/mds.27326. Epub 2018 Mar 23.
8
An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity.交感神经调节免疫应答在感染性疾病和自身免疫中的作用概述。
Int J Hyperthermia. 2018 Mar;34(2):135-143. doi: 10.1080/02656736.2017.1411621.
9
Norepinephrine Inhibits Th17 Cells via β2-Adrenergic Receptor (β2-AR) Signaling in a Mouse Model of Rheumatoid Arthritis.去甲肾上腺素通过β2 肾上腺素能受体(β2-AR)信号抑制类风湿关节炎小鼠模型中的 Th17 细胞。
Med Sci Monit. 2018 Feb 27;24:1196-1204. doi: 10.12659/msm.906184.
10
Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.肾上腺素能信号:限制抗肿瘤免疫反应发展的可靶向检查点。
Front Immunol. 2018 Feb 6;9:164. doi: 10.3389/fimmu.2018.00164. eCollection 2018.